Abstract
We report the successful management of a case of hemolytic disease and hydrops fetalis secondary to anti Rh 17 antibodies in a woman with the rare D−− phenotype. We discuss the efficacy of intravenous immunoglobulins in treating hemolytic disease of the newborn infant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Race RR, Sanger R . Blood Groups in Man 6th ed London: Blackwell 1975 p 215
Deitenbeck R, Tutschek B, Crombach G, Stannigel H . Successful management of pregnancy and hemolytic disease of the newborn due to anti-Hro in a woman of the D−− phenotype Transfusion 1999 39: 1151–2
Han KS, Kim HC, Han KS, Shim WS . A case of fatal hemolytic disease of the newborn associated with −D−/−D− phenotype Am J Perinatol 1997 14: 495–7
Daniels G . Human Blood Group Oxford: Blackwell 1995 p 313–5
Raynal V, D'ambrasio A-M, Carton JP, Colin Y . Molecular analysis of the structure and expression of RH locus in individuals with D−−, Dc− and Dcw gene complex Blood 1994 5: 62–5
Hisanaga S, Shimokawa H, Kurokawa T, Maesato S, Nakano H . Relation of the site of congenital upper gastrointestinal obstruction to amniotic fluid bilirubin concentration Asia Oceania J Obstet Gynaecol 1983 9: 435–8
Mari G, Detr RL, Carpenter RL et al. Non invasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses N Engl J Med 2000 342: 9–14
Hammerman C, Kaplan M, Vremon HJ, Stevenson DK . Intravenous immunoglobulin in neonatal ABO isoimmunization: factors associated with clinical efficacy Biol Neonat 1996 70: 69–74
Hammerman C, Vreman HJ, Kaplan M, Stevenson DK . Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Acta Paediatr 1996 November 85: 11 1351–3
Tanyer G, Siklar Z, Dallar Y, Yildirmak Y, Tiras U . Multiple dose IVIG treatment in neonatal immune hemolytic jaundice J Trop Pediatr 2001 47: 50–3
Voto LS, Sexer H, Ferreiro G, Tavosnanska J, Orti J, Mathet ER, Margulies M, Margulies M . Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease J Perinat Med 1995 23: 443–51
Dagoglu T, Ovali F, Samanci N, Bengisu E . High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease J Int Med Res 1995 23: 264–71
Rubo J, Albrecht K, Lasch P . High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease J Pediatr 1992 121: 93–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aref, K., Boctor, F., Pande, S. et al. Successful Perinatal Management of Hydrops Fetalis Due to Hemolytic Disease Associated with D−− Maternal Phenotype. J Perinatol 22, 667–668 (2002). https://doi.org/10.1038/sj.jp.7210775
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210775
This article is cited by
-
Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D−− phenotype
International Journal of Hematology (2020)
-
Successful transfusion care for a patient with the Rhesus -D- phenotype and antibodies against Rh17 and two additional alloantibodies
Annals of Hematology (2012)
-
Fetal intraperitoneal injection of immunoglobulin diminishes alloimmune hemolysis
Journal of Perinatology (2011)